Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 23, Number 5—May 2017

Research Letter

Zika Virus Infection and Prolonged Viremia in Whole-Blood Specimens

Jean Michel MansuyComments to Author , Catherine Mengelle, Christophe Pasquier, Sabine Chapuy-Regaud, Pierre Delobel, Guillaume Martin-Blondel, and Jacques Izopet
Author affiliations: Centre Hospitalier Universitaire de Purpan, Toulouse, France (J.M. Mansuy, C. Mengelle, C. Pasquier, S. Chapuy-Regaud, P. Delobel, G. Martin-Blondel, J. Izopet); Institut National de la Santé et de la Recherche Médicale, Toulouse (C. Pasquier, S. Chapuy-Regaud, P. Delobel, G. Martin-Blondel, J. Izopet); Université Paul Sabatier, Toulouse (C. Pasquier, S. Chapuy-Regaud, P. Delobel, J. Izopet)

Main Article

Figure

A) Zika virus viremia in whole blood and plasma from 5 immunocompetent patients in France (identified by sex and age, y) who had traveled to Central or South America or the Caribbean. B) Zika viral load in whole-blood (n = 23) and plasma (n = 10) samples from a point-to-point comparison of positive samples. Horizontal lines indicate mean +SE. LOD, limit of detection; PL, plasma; WB, whole blood.

Figure. A) Zika virus viremia in whole blood and plasma from 5 immunocompetent patients in France (identified by sex and age, y) who had traveled to Central or South America or the Caribbean. B) Zika viral load in whole-blood (n = 23) and plasma (n = 10) samples from a point-to-point comparison of positive samples. Horizontal lines indicate mean +SE. LOD, limit of detection; PL, plasma; WB, whole blood.

Main Article

TOP